Specific clinical and radiological characteristics of anti-NMDA receptor autoimmune encephalitis following herpes encephalitis
- PMID: 39147951
- PMCID: PMC11447135
- DOI: 10.1007/s00415-024-12615-7
Specific clinical and radiological characteristics of anti-NMDA receptor autoimmune encephalitis following herpes encephalitis
Abstract
Background: Herpes simplex virus encephalitis (HSE) frequently triggers secondary anti-N-methyl-D-aspartate receptor encephalitis (NMDARE), but markers predicting the occurrence of this entity (HSE-NMDARE) are lacking.
Methods: We conducted a retrospective description of patients with HSE-NMDARE diagnosed between July 2014 and August 2022 and compared them to both patients with regular forms of HSE and NMDARE.
Results: Among the 375 patients with NMDARE, 13 HSE-NMDARE were included. The median age was 19 years (0.5-73), 4/13 (31%) were children < 4 years old, and 7/13 (54%) were male. The median time between HSE and NMDARE onset was 30 days (21-46). During NMDARE, symptoms differed from HSE, including increased behavioral changes (92% vs 23%, p = 0.008), movements disorders (62% vs 0%, p = 0.013), and dysautonomia (54% vs 0%, p = 0.041). Compared to 21 patients with regular HSE, patients with HSE-NMDARE more often achieved severity-associated criteria on initial MRIs, with extensive lesions (11/11, 100% vs 10/21, 48%, p = 0.005) and bilateral diffusion-weighted imaging sequence abnormalities (9/10, 90% vs 6/21, 29%, p = 0.002). Compared to 198 patients with regular NMDARE, patients with HSE-NMDARE were more frequently males (7/13, 54% vs 43/198, 22%; p = 0.015) and children < 4 (4/13, 31% vs 14/198, 7%; p = 0.016), with a worse 12-month mRS (2[1-6] vs 1[0-6], p = 0.023).
Conclusions: Herein, patients with HSE-NMDARE have a poorer long-term prognosis than patients with regular NMDARE. We report a greater rate of severity-associated criteria on initial MRIs for HSE-NMDARE compared to regular HSE, which may help identify patients with higher risk of HSE-NMDARE.
Keywords: N-methyl-d-aspartate receptor; Antibody-mediated encephalitis; Infectious encephalitis; Post-infectious.
© 2024. The Author(s).
Conflict of interest statement
The authors report no competing interests.
Figures




References
-
- Granerod J, Ambrose HE, Davies NW, Clewley JP, Walsh AL, Morgan D et al (2010) Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect Dis 10:835–844. 10.1016/S1473-3099(10)70222-X - PubMed
-
- Modi S, Mahajan A, Dharaiya D, Varelas P, Mitsias P (2017) Burden of herpes simplex virus encephalitis in the United States. J Neurol 264:1204–1208. 10.1007/s00415-017-8516-x - PubMed
-
- Armangue T, Spatola M, Vlagea A, Mattozzi S, Cárceles-Cordon M, Martinez-Heras E et al (2018) Frequency, syndromes, risk factors, and outcome of autoimmune encephalitis following herpes simplex encephalitis: a prospective observational study and a retrospective analysis of cases. Lancet Neurol 17:760–772. 10.1016/S1474-4422(18)30244-8 - PMC - PubMed
-
- Armangué T. Neurologic complications in herpes simplex encephalitis: clinical, immunological and genetic studies n.d. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources